News

Track TBI Study Published in JAMA Neurology

– Landmark study in mild TBI (mTBI), supported in part by a grant from NeuroTrauma Sciences, helps define CT (computed tomography) scan features associated with adverse outcomes after mTBI   –

A head computed tomography (CT) with positive results for acute intracranial hemorrhage is the gold-standard diagnostic biomarker for acute traumatic brain injury (TBI).  In moderate to severe TBI, some CT features have been shown to be associated with certain outcomes.  In mild TBI, distribution and co-occurrence of pathological CT features and their prognostic importance are not well understood.

In a first-of-its-kind study, TRACK-TBI investigators, under the direction of Geoffrey T. Manley, MD, PhD, Department of Neurological Surgery, University of California, San Francisco, and with external validation from CENTER-TBI, under the direction of Andrew I.R. Maas, MD, PhD and Geoffrey T. Manley, MD, PhD, identified pathological CT features associated with adverse outcomes after mTBI and concluded that pathological features on head computed tomography carried different implications for mild traumatic brain injury prognosis to one year…

NeuroTrauma Sciences Enters Collaboration to Support “CENTER-TBI” Research in Traumatic Brain Injury

NeuroTrauma Sciences, LLC (NTS) today announced it has entered into a research collaboration with Antwerp University Hospital, Belgium, to help support “Collaborative European NeuroTrauma Effectiveness Research in TBI” (CENTER-TBI), a prospective longitudinal observational study that is collecting clinical and epidemiological data to identify the most effective clinical care and...

NeuroTrauma Sciences Announces Expansion of Its Executive Leadership Team

NeuroTrauma Sciences, LLC (NTS), a private biopharmaceutical company developing a portfolio of disease-modifying therapeutic candidates to treat the devastating effects of acquired brain injury, today announced the expansion of its executive management team with several key appointments...